The Association of Human Papillomavirus Type 16 E6 and E7 Antibodies with Stage of Cervical Cancer

By Fisher S.G.   Benitez-Bribiesca L.   Nindl I.   Stockfleth E.   Muller M.   Wolf H.   Perez-Garcia F.   Guzman-Gaona J.   Gutierrez-delgado F.   Irvin W.   Gissmann L.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 73-78

Academic Press

Access to resources Recommend Favorite

Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients

By Benevolo Maria   Terrenato Irene   Mottolese Marcella   Marandino Ferdinando   Carosi Mariantonia   Rollo Francesca   Ronchetti Livia   Muti Paola   Mariani Luciano   Sindico Stefano   Vocaturo Giuseppe   Vocaturo Amina  

Cancer Causes and Control, Vol. 22, Iss. 6, 2011-06 ,pp. : 869-875

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of p53 and Bcl-2 Expression as Prognostic Markers in Invasive Cervical Carcinoma Stage IIb/III Patients Treated by Radiotherapy

By Jain D.   Srinivasan R.   Patel F.D.   Kumari Gupta S.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 22-28

Academic Press

Access to resources Recommend Favorite

Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination

By Franco Eduardo L   Ferenczy Alex  

Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. : 319-327

Future Medicine

Access to resources Recommend Favorite

Detection of human papillomavirus and expression of osteopontin in cervical cancer specimens

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 447-453

Spandidos Publications

Access to resources Recommend Favorite